January 19, 2020
I am pleased to share HSC has received our first, albeit limited, supply of the Moderna COVID-19 vaccine. I know there have been many questions about who will receive the vaccine and when, so I want to share our distribution plan and the rationale for it.
HSC Health submitted an application to the State to administer the COVID-19 vaccine as soon as the application portal opened several weeks ago. As a clinical operation with 120,000+ annual patient encounters, we applied for approval as a heath care provider. Per the terms of our application, we are required to allocate the vaccine in the following order of priority:
- HSC Health clinical staff
- HSC campus employees who fall into the Phase 1A distribution category as defined by the Texas Department of State Health Services (DSHS)
- HSC Health patients
We received an initial shipment of 300 vaccines and our distribution plan for next week is as follows (in compliance with DSHS):
- HSC Health providers and staff with direct patient care 90
- Facilities/custodial staff within HSC Health 10
- Campus Police 16
- Willed Body Program (Last Responders) 16
- Institute for Translational Research (with direct patient contact) 18
- HSC Health patients 75+ with at least one chronic condition 150
If you are among the HSC team members identified to participate in the initial round of vaccinations, you will receive an email with a link to schedule an appointment with HSC Health. As a reminder, while it is highly recommended you are not required to receive a COVID-19 vaccination.
We will be submitting a request for additional vaccines as soon as possible and will update you with more information as it becomes available. In the interim, if you are a Phase 1A or Phase 1B candidate, I encourage you to register for a vaccine at one of the following links:
I want to thank our HSC Health leaders for working tirelessly to secure our initial supply of the vaccine. The health, safety and well-being of all our team members and patients is our top-priority, and I assure you we will continue to pursue more vaccines and distribute them in a fair and equitable manner.
Dr. Michael R. Williams